31 research outputs found

    Effect of Temperature on Cystic Fibrosis Lung Disease and Infections: A Replicated Cohort Study

    Get PDF
    Progressive lung disease accounts for the majority of morbidity and mortality observed in cystic fibrosis (CF). Beyond secondhand smoke exposure and socio-economic status, the effect of specific environmental factors on CF lung function is largely unknown.Multivariate regression was used to assess correlation between specific environmental factors, the presence of pulmonary pathogens, and variation in lung function using subjects enrolled in the U.S. CF Twin and Sibling Study (CFTSS: nβ€Š=β€Š1378). Significant associations were tested for replication in the U.S. CF Foundation Patient Registry (CFF: nβ€Š=β€Š16439), the Australian CF Data Registry (ACFDR: nβ€Š=β€Š1801), and prospectively ascertained subjects from Australia/New Zealand (ACFBAL: nβ€Š=β€Š167).In CFTSS subjects, the presence of Pseudomonas aeruginosa (ORβ€Š=β€Š1.06 per Β°F; p<0.001) was associated with warmer annual ambient temperatures. This finding was independently replicated in the CFF (1.02; p<0.001), ACFDR (1.05; pβ€Š=β€Š0.002), and ACFBAL (1.09; pβ€Š=β€Š0.003) subjects. Warmer temperatures (-0.34 points per Β°F; pβ€Š=β€Š0.005) and public insurance (-6.43 points; p<0.001) were associated with lower lung function in the CFTSS subjects. These findings were replicated in the CFF subjects (temperature: -0.31; p<0.001; insurance: -9.11; p<0.001) and similar in the ACFDR subjects (temperature: -0.23; pβ€Š=β€Š0.057). The association between temperature and lung function was minimally influenced by P. aeruginosa. Similarly, the association between temperature and P. aeruginosa was largely independent of lung function.Ambient temperature is associated with prevalence of P. aeruginosa and lung function in four independent samples of CF patients from two continents

    A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies

    Get PDF
    Genetic studies of lung disease in Cystic Fibrosis are hampered by the lack of a severity measure that accounts for chronic disease progression and mortality attrition. Further, combining analyses across studies requires common phenotypes that are robust to study design and patient ascertainment

    Variation in MSRA Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis

    Get PDF
    Meconium ileus (MI), a life-threatening intestinal obstruction due to meconium with abnormal protein content, occurs in approximately 15 percent of neonates with cystic fibrosis (CF). Analysis of twins with CF demonstrates that MI is a highly heritable trait, indicating that genetic modifiers are largely responsible for this complication. Here, we performed regional family-based association analysis of a locus that had previously been linked to MI and found that SNP haplotypes 5β€² to and within the MSRA gene were associated with MI (Pβ€Š=β€Š1.99Γ—10βˆ’5 to 1.08Γ—10βˆ’6; Bonferroni Pβ€Š=β€Š0.057 to 3.1Γ—10βˆ’3). The haplotype with the lowest P value showed association with MI in an independent sample of 1,335 unrelated CF patients (ORβ€Š=β€Š0.72, 95% CI [0.53–0.98], Pβ€Š=β€Š0.04). Intestinal obstruction at the time of weaning was decreased in CF mice with Msra null alleles compared to those with wild-type Msra resulting in significant improvement in survival (Pβ€Š=β€Š1.2Γ—10βˆ’4). Similar levels of goblet cell hyperplasia were observed in the ilea of the Cftrβˆ’/βˆ’ and Cftrβˆ’/βˆ’Msraβˆ’/βˆ’ mice. Modulation of MSRA, an antioxidant shown to preserve the activity of enzymes, may influence proteolysis in the developing intestine of the CF fetus, thereby altering the incidence of obstruction in the newborn period. Identification of MSRA as a modifier of MI provides new insight into the biologic mechanism of neonatal intestinal obstruction caused by loss of CFTR function

    Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2

    Get PDF
    A combined genome-wide association and linkage study was used to identify loci causing variation in CF lung disease severity. A significant association (P=3. 34 Γ— 10-8) near EHF and APIP (chr11p13) was identified in F508del homozygotes (n=1,978). The association replicated in F508del homozygotes (P=0.006) from a separate family-based study (n=557), with P=1.49 Γ— 10-9 for the three-study joint meta-analysis. Linkage analysis of 486 sibling pairs from the family-based study identified a significant QTL on chromosome 20q13.2 (LOD=5.03). Our findings provide insight into the causes of variation in lung disease severity in CF and suggest new therapeutic targets for this life-limiting disorder

    Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis

    Get PDF
    Variants associated with meconium ileus in cystic fibrosis (CF) were identified in 3,763 patients by GWAS. Five SNPs at two loci near SLC6A14 (min P=1.28Γ—10βˆ’12 at rs3788766), chr Xq23-24 and SLC26A9 (min P=9.88Γ—10βˆ’9 at rs4077468), chr 1q32.1 accounted for ~5% of the phenotypic variability, and were replicated in an independent patient collection (n=2,372; P=0.001 and 0.0001 respectively). By incorporating that disease-causing mutations in CFTR alter electrolyte and fluid flux across epithelia into an hypothesis-driven genome-wide analysis (GWAS-HD), we identified the same SLC6A14 and SLC26A9 associated SNPs, while establishing evidence for the involvement of SNPs in a third solute carrier gene, SLC9A3. In addition, GWAS-HD provided evidence of association between meconium ileus and multiple constituents of the apical plasma membrane where CFTR resides (P=0.0002, testing 155 apical genes jointly and replicated, P=0.022). These findings suggest that modulating activities of apical membrane constituents could complement current therapeutic paradigms for cystic fibrosis

    Heritability of Lung Disease Severity in Cystic Fibrosis

    No full text
    Rationale: Obstructive lung disease, the major cause of mortality in cystic fibrosis (CF), is poorly correlated with mutations in the disease-causing gene, indicating that other factors determine severity of lung disease
    corecore